财报解读|对外授权收入助攻,诺诚健华业绩首次实现盈利

第一财经
13 May

5月13日晚间,诺诚健华(09969.HK、688428.SH)发布的一季报显示,公司业绩扭亏为盈。  具体是,今年第一季度,公司实现总收入达到3.81亿元,同比增长129.92%;归属于上市公司股东的净利润0.18亿元,这也是公司成立以来首次业绩实现盈利。  对于业绩增长,诺诚健华主要归功于核心产品奥布替尼(商品名:宜诺凯)的持续放量以及公司与Prolium达成授权许可获得的首付款。  奥布...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10